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Abstract: Plant phenolics have shown to activate apoptotic cell death in different tumourigenic
cell lines. In this study, we evaluated the effects of juniper berry extract (Juniperus communis L.)
on p53 protein, gene expression and DNA fragmentation in human neuroblastoma SH-SY5Y cells.
In addition, we analyzed the phenolic composition of the extract. We found that juniper berry extract
activated cellular relocalization of p53 and DNA fragmentation-dependent cell death. Differentially
expressed genes between treated and non-treated cells were evaluated with the cDNA-RDA
(representational difference analysis) method at the early time point of apoptotic process when p53
started to be activated and no caspase activity was detected. Twenty one overexpressed genes related
to cellular stress, protein synthesis, cell survival and death were detected. Interestingly, they included
endoplasmic reticulum (ER) stress inducer and sensor HSPA5 and other ER stress-related genes
CALM2 and YKT6 indicating that ER stress response was involved in juniper berry extract mediated
cell death. In composition analysis, we identified and quantified low concentrations of fifteen
phenolic compounds. The main groups of them were flavones, flavonols, phenolic acids, flavanol
and biflavonoid including glycosides of quercetin, apigenin, isoscutellarein and hypolaetin. It is
suggested that juniper berry extract induced the p53-associated apoptosis through the potentiation
and synergism by several phenolic compounds.
Keywords: apoptosis; Juniperus communis L.; plant extract; ER stress; p53; SH-SY5Y neuroblastoma cells
1. Introduction
Cell signaling pathways related to apoptosis and cell cycle have an essential role in development
and progression of complex diseases such as cancer. One of the key orchestrators of those cellular
functions is the tumour protein p53 [1]. The fact that p53 dysfunctions in most cancers indicates
its essential role in tumour suppression: p53 has been found to be mutated in half of the cases
while other cases often possess dysregulation of its upstream signaling pathways [2]. Cellular stress,
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including DNA damage, ribosomal and endoplasmic reticulum stress activates p53 whereas its levels
are strictly maintained low under normal conditions. Activated p53 translocates into the nucleus
where it modulates the expression of over hundred genes [3]. Furthermore, p53 acts in cytoplasm
where it regulates the mitochondrial membrane permeabilization and directly interacts with other
proteins [4,5]. In addition to these well-known tumour suppressing activities of p53, recent studies
have revealed that it has a central role in tumour-related metabolism, cell-cell communication and
metastasis as well [1].
Juniper (Juniperus communis L., Cupressaceae) is an evergreen coniferous shrub or small tree
growing on the temperate regions of the northern hemisphere. Mature female cones of juniper are
generally called berries for their “berry-like” appearance, and they are used to flavour game meat and
alcoholic beverages, e.g., gin and beer. In traditional herbal medicine juniper has been used for many
purposes as e.g., treating wounds, pain, fevers, rheumatism, snakebites, swellings, gastrointestinal
infections, bronchitis and cancers [6,7] and it has been claimed to possess also diuretic, antiseptic,
carminative, stomachic and antirheumatic properties [8].
Although juniper berries are mainly used for their aromatic properties, they also contain bioactive
plant phenolics, e.g., quercetin glycosides [9], which might explain at least some of the claimed
health-promoting effects of juniper. It is known that naturally derived phenolic compounds can
affect different cell signalling pathways inducing both cell cycle progression and apoptosis [10].
The mechanisms of single compounds have been studied more closely but the interest on the mixtures
of compounds or plant extracts has been raised over the last years [11]. Suggested benefits of using
combinations of different therapeutic agents include reduced toxicity based on the lower-dose usage
of drugs and decreased development of drug resistance [12].
We have shown earlier that the juniper berry extract can induce a p53-dependent cell death in
human SH-SY5Y neuroblastoma cells [13]. In addition, the anti- and pro-oxidant capacities of the
extract have been analysed in biochemical test models [14]. In these studies, the juniper berry extract
was prepared using a hydrodistillation process to remove volatile compounds [15], and their absence
was verified with chromatographic analysis. Therefore, the observed anti- and/or pro-oxidant and cell
death-inducing effects of the extract did not result from toxicity of volatile compounds but rather by
specific non-volatile compounds mediated cellular mechanisms [13,14]. Studies on the bioactivity of
juniper berry extracts without volatile components are rare in literature.
In the present work, we have studied the phenolic composition and biological effects of aqueous
juniper berry extract in more detail. Therefore, we have examined the mechanisms of juniper extract
induced apoptosis by analyzing the p53 translocation, and gene expression and DNA fragmentation.
The identification and quantification of phenolic compounds was performed using chromatographic
methods. The results showed that the juniper extract contained several compounds with cell cycle and
apoptosis regulating effects. The extract treatment of human SH-SY5Y neuroblastoma cells resulted
in the increased DNA damage, p53 translocation from the cytoplasmic to nuclear compartment and
overexpression of several genes in parallel with the reactivation of impaired apoptosis.
2. Results
2.1. Phenolic Composition of Aqueous Juniper Berry Extract
Thirteen flavonoid glycosides and two phenolic acids (procatechuic acid and rosmarinic acid)
were identified and quantified from the extract (Figure 1A, Table 1). Flavonoids included five flavonols
(gossypetin-hexoside-pentoside, hyperoside, kaempferol-3-O-glucoside, quercetin pentoside, rutin);
six flavones (apigenin-7-O-glucoside, isoscutellarein-8-O-pentoside, isoscutellarein-7-O-pentoside,
hypolaetin hexoside, hypolaetin-7-O-pentoside, luteolin) and one flavanol (catechin). Among biflavonoids,
only a small amount of amentoflavone was detected. However, traces of five other biflavonoids were
found in quadrupole time of flight (QTOF) analyses by single ion monitoring at m/z 537 [M ´ 1] and
at m/z 551 [M ´ 1] (Figure 1B). In addition, numerous polar compounds eluting at shorter retention
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times were characteristic in the LC-MS-UV analysis, but those compounds remained unidentified
(a–d, Figure 1A). Overlapping peaks such as 4 and 5 (Figure 1) were separated into two compounds
rutin m/z 609 [M ´ 1] and hyperoside m/z 463 [M ´ 1] by ultra-performance liquid chromatograhy
(UPLC)-QTOF analysis. Free aglycones such as apigenin and quercetin or volatile oils components
were not detected in extract.
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Figure 1. Analysis of the compounds of Juniper communis extract. (A) LC-MS-UV-chromatogram of 
water extract of juniper berries (280 nm); compound (a) m/z 191 (100), 353 [M − 1]; (b) m/z 169 [M − 1]; 
(c) m/z 539 (100); (d) m/z 443 (100); and (B) the iongram profiles of biflavones at m/z 537 and 551 
obtained by quadrupole time of flight-electrospray ion (QTOF-ESI)-analysis. Numbered peaks see  
Table 1. X-axis is arbitary units, Y-axis is time in min. 
Figure 1. Analysis of the compounds of Juniper communis extract. (A) LC-MS-UV-chromatogram
of water extract of juniper berries (280 nm); compound (a) m/z 191 (100), 353 [M ´ 1]; (b) m/z 169
[M ´ 1]; (c) m/z 539 (100); (d) m/z 443 (100); and (B) the iongram profiles of biflavones at m/z 537 and
551 obtained by quadrupole time of flight-electrospray ion (QTOF-ESI)-analysis. Numbered peaks see
Table 1. X-axis is arbitary units, Y-axis is time in min.
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Table 1. Identification and quantification of phenolic compounds in aqueous juniper berry extract.
Peak Compounds Rt min a λmax nm Mw
b ESI-MS´
Ions m/z
MRM Ions Amounts inExtract µg/g
Amounts in Treatments
(10 µg/mL of Extract) nM (ng/mL) References
1 Protocatechuic acid 11.11 260, 293 154 153, 109 153Ñ109 412 d 26.75 (4.12) [16]
2 Catechin 13.69 280 290 289, 245, 205 - 406 e 14.00 (4.06) [17]
3 Gossypetin-hexoside-pentoside 15.07 271, 367 612 611, 479 - 155 e 2.53 (1.55) [18]
4 Rutin 20.97 255, 354 610 609 609Ñ301 1333 d 21.85 (13.33) [9]
5 Hyperoside 21.14 255, 353 464 463, 301 463Ñ300 561 d 12.09 (5.61) [9]
6 Quercetin pentoside 24.09 275, 341 434 433, 301 - 174 e 4.01 (1.74) [18]
7 Isoscutellarein-8-O-hexoside 24.72 276, 303, 327 448 447, 285, 895 c - 427 e 9.53 (4.27) [9,18,19]
8 Hypolaetin-7-O-pentoside 25.00 275, 342 434 433, 301, 867 c - 887 e 20.44 (8.87) [9,18,19]
9 Apigenin-7-O-glucoside 25.63 267, 338 432 431, 269 431Ñ268 1646 d 38.10 (16.46) [9,18]
10 Luteolin pentoside 26.16 273, 347 418 417, 285 - 109 e 2.61 (1.09) [9]
11 Hypolaetin hexoside 26.79 257, 343 464 463, 301, 867 c - 305 e 6.57 (3.15) [9]
12 Isoscutellarein-7-O-pentoside 27.25 275, 304, 326 418 417, 285, 835 c - 798 e 19.09 (7.98) [9,18]
13 Kaempferol-3-O-glucoside 27.38 266, 346 448 447, 285 447Ñ284 250 d 5.58 (2.50) [17]
14 Rosmarinic acid 27.56 329 360 359, 161 359Ñ161 103 d 2.86 (1.03) [20]]
15 Amentoflavone 37.40 268, 340 538 537 537Ñ375 167 d 3.10 (1.67) [9,18]
a High performance liquid chromatography (HPLC)-DAD; b [M ´ 1] (100%), full scan mode; c detected by ESI-QTOF-MS´; d quantitation based on calibration curves; e calculated
as rutin. References [9,21–25] et al. 2006. ESI: Electrospray ion; QTOF: Quadrupole time of flight; MS: Mass spectrometry; MRM: Multiple reaction monitoring; Rt: running time;
Mw: molecular weight.
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2.2. Identified Phenolics and Concentrations
The content of total phenols determined as gallic acid equivalents accounted for 18.5 mg/g
dried juniper berry extract [15]. Identified and quantified phenolic compounds comprised 42% of
reported total phenols content, and they represented 7733 µg/g (0.77%) of the dry weight of extract.
Flavones (flavonoids) comprised 54% of identified compounds, flavonols (flavonoids) 32%, phenolic
acids 7%, flavanol (flavonoid) 5% and biflavonoid 2%. The main identified compounds were quercetin
glycosides (27% of identified compounds), apigenin glycoside (21%), isoscutellarein glycosides (16%)
and hypolaetin glycosides (15%). The four most abundant flavonoid glycosides (800–1650 µg/g) were
apigenin-7-glucoside, rutin, hypolaetin-7-pentoside and isoscutellarein-7-O-pentoside. Concentrations
of single compounds in cell treatments with 10 µg/mL of extract were calculated according to
molecular weight data obtained from phenolic composition analysis (Table 1). Concentrations of
single compounds in treatments varied from 2.53 to 38.10 nM.
2.3. Localization of Protein p53 in Cytoplasm and Nucleus
The accumulation of p53 after a 12 h-treatment with the juniper berry extract in human
neuroblastoma SH-SY5Y cells was about two fold, i.e., in the same level than in our previous study [13]
with statistically significant increases. Here we show that the accumulated p53 starts to translocate
into the nucleus 12 h after treatment, and the highest nuclear p53 concentrations were detected after
24, 36 and 48 h (Figure 2). Translocation of p53 declines after 72 h of treatment. Observations were
statistically significant after 36 and 48 h of treatment. The amount of cytoplasmic p53 is stable within
the treatments when compared to the untreated control cells although the variation of nuclear amounts
was detected between treatments. These observations suggest the transcriptional activation of p53
after treatment with juniper berry extract.
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Figure 2. The amount of protein p53 in cytoplasmic and nuclear fractions of SH-SY5Y neuroblastoma 
cells at different time points after treatment with 10 µg/mL of juniper berry extract (A); The western 
blot analysis of p53 amount at different time points (B). Values are means ± SEM of protein amounts 
of treated cells compared to the untreated control cells from three independent experiments. 
Statistical significance was determined using a one-tailed Student’s t-test; * p < 0.05. 
Figure 2. The amount of protein p53 in cytoplasmic and nuclear fractions of SH-SY5Y neuroblastoma
cells at different time points after treatment with 10 µg/mL of juniper berry extract (A); The western
blot analysis of p53 a ount at different time points (B). Values are means ˘ SEM of protein
amounts of treated cells compar d to the ntre ted control cells from three independent experiments.
Statistical significance was determined using a one-tailed Student’s t-test; * p < 0.05.
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2.4. DNA Fragmentation and Morphology
Fragmented DNA was detected first after 24 h-treatment but the most abundant laddering was
detected after a 72 h-treatment (Figure 3A). The DNA of non-treated control cell was also analyzed
(results not shown) and some minor breakage of DNA was detected later after 48 and 72 h but not 24 h
after treatment. In addition, the visible DNA ladders were remarkably weaker compared to ladders
detected from treated cells. Morphological changes in the treated and non-treated cells were observed
by a microscopic examination. After the 12 h-treatment before the cell death occurred, the amount
of 56% (SD 2.5, median 56) of treated cells were slightly shrunk and membranes slightly disrupted
compared to the non-treated control cells but the amount of floating dead cells was comparable to
the non-treated cells (Figure 2B,C). The detachment of cells increased gradually 24, 36, 48 and 72 h
after the treatment. The breakage of DNA is one of the final steps of apoptotic cell death [26], and it is
described as a hallmark of apoptosis [27]. These results suggest that the juniper berry extract induced
the apoptotic cell death after 24 h of treatment.
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examined by the cDNA representational difference analysis (RDA) to detect overexpressed genes  
in treated cells in comparison to non-treated control cells. This polymerase chain reaction-based, 
qualitative technique is able to detect very small mRNA-level differences in gene expression. The 
gene expression was analyzed at the time point when the amount of p53 starts to accumulate but 
there are no detectable apoptotic features of cell death. 
Twenty one overexpressed protein-coding genes were identified by BLAST search (Table 2).  
To clarify the varied nomenclature of genes and proteins, their preferred names and synonyms are 
listed in Table 3. To analyze the functions of proteins encoded by differentially expressed genes,  
they were assessed using literature search and UniProt KB and SwissProt databases (Table 4). Proteins 
were subdivided to seven different functional groups: cell death and cell survival proteins, cell cycle 
proteins, cellular stress proteins, cell shape, motility and polarity proteins, protein synthesis proteins, 
Figure 3. Features of cell death in neuroblastoma SH-SY5Y cells after treatment with 10 µg/mL of
juniper berry extract. Fragmented DNA at different time points after treatment (A); Non-treated (B)
and treated cells (C) after 12 h-treatment. The amount of 56% (SD 2.5, median 56, n = 3) of treated
cells were morphologically slightly changed after treatment. The arrows point the slight shrinkage and
membrane disruption of treated cells compared to non-treated cells. Original magnification of cells
was 10ˆ.
2.5. Differentially Expressed Genes
Changes in gene expression caused by the 12 h-treatment with juniper berry extract were examined
by the cDNA representational difference analysis (RDA) to detect overexpressed genes in treated cells
in comparison to non-treated control cells. This polymerase chain reaction-based, qualitative technique
is able to detect very small mRNA-level differences in gene expression. The gene expression was
analyzed at the time point when the amount of p53 starts to accumulate but there are no detectable
apoptotic features of cell death.
Twenty one overexpressed protein-coding genes were identified by BLAST search (Table 2).
To clarify the varied nomenclature of genes and proteins, their preferred names and synonyms
are listed in Table 3. To analyze the functions of proteins encoded by differentially expressed
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genes, they were assessed using literature search and UniProt KB and SwissProt databases (Table 4).
Proteins were subdivided to seven different functional groups: cell death and cell survival proteins,
cell cycle proteins, cellular stress proteins, cell shape, motility and polarity proteins, protein synthesis
proteins, Ca2+-signaling proteins and proteins with enzymatic and protein-protein interactions. Further,
the interactions of proteins with each other, p53 and cell death or survival were refined by STRING
analysis accompanied with literature search (Figures 4 and 5).
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Table 2. Differentially expressed genes and predicted proteins encoded by them. Differentially expressed
genes were detected and sequenced from the purified mRNA of SH-SY5Y cells after 12 h treatment
with 10 µg/mL of juniper berry extract by cDNA-RDA (representational difference analysis) method.
Sequences were analyzed in BLASTN 2.2.27+ using human G + T databases. NM: accession number.
Gene Accession Number Score E-Value Length
ALKBH5 NM_017758 706 0.0 988
ARHGAP35 NM_004491 771 0.0 948
CALM2 NM_001743 499 2 ˆ 10´138 663
CSDE1 NM_001242893+ 627 1 ˆ 10´176 720
EIF3A NM_003750 508 4 ˆ 10´141 706
GNAS NM_003259+ 669 0.0 899
HSPA5 NM_005347 682 0.0 683
ITFG3 NM_032039 647 0.0 939
MAT2A NM_005911 363 4 ˆ 10´97 363
MORF4L1 NM_006791 392 3 ˆ 10´106 515
PPAPDC1B NM_001102559+ 453 2 ˆ 10´124 833
PRSS12 NM_003619 508 5 ˆ 10´141 859
RAC1 NM_006908+ 536 2 ˆ 10´149 908
RPL6 NM_001024662 508 5 ˆ 10´141 869
RPLP0 NM_001002+ 623 2 ˆ 10´175 874
SEMA3C NM_006379 616 3 ˆ 10´173 907
SF3B2 NM_006842 544 1 ˆ 10´151 932
STRADA NM_153335 468 9 ˆ 10´129 998
STRN4 NM_013403 608 3 ˆ 10´171 663
TTC37 NM_014639 573 1 ˆ 10´160 702
YKT6 NM_006555 621 5 ˆ 10´175 792
Table 3. Nomenclature of differentially expressed genes and predicted proteins encoded by them.
Gene synonyms are from the database of Hugo Gene Nomenclature Committee (HGNC) maintained
by the European Bioinformatic Institute. Names of predicted proteins and their synonyms are from
UniProtKB and Swiss-Prot databases.
Gene Gene Full Name/Synonyms Protein(s) Encoded/Synonyms
ALKBH5 Alkylating repair homolog 5 (E. coli)/ABH5 RNA demethylase ALKBH5
ARHGAP35 Rho GTPase activating protein 35/GRF1 Rho GTPase activating protein 35/GRF1/p190-A
CALM2 Calmodulin 2 (phosphorylase kinase, delta)/CAM2 Calmodulin/CaM
CSDE1 Cold shock domain containing E1/UNR Cold shock domain-containing protein E1/UNR
EIF3A Eukaryotic translation initiation factor 3, subunit A Eukaryotic translation initiation factor 3, subunit A/eIF3a
GNAS GNAS complex locus/NESP
ALEX
Guanine nucleotide-binding protein G(s), subunit alpha
isoform Xlas/Xlalpha
Guanine nucleotide-binding protein G(s), subunit alpha
isoform Short
Neuroendocrine secretory protein 55/NESP55
HSPA5 Heat shock 70 kDa protein 5/GRP78 78 kDa glucose-regulated protein/GRP78/BiP
ITFG3 Integrin alpha FG-GAP repeat containing 3 ITFG3
MAT2A Methionine adenosyltransferase II/MATA2 S-adenosylmethionine synthase, isoform type-2/MAT2
MORF4L1 Mortality factor 4 like 1/Eaf3/MRG15 Mortality factor 4-like protein 1/MRG15
PPAPDC1B Phosphatidic acid phosphatase type 2, domaincontaining 1B/HTPAP Phosphatide phosphatase PPAPDC1B/HTPAP/DPPL1
PRSS12 Protease, serine, 12 (neurotrypsin, motopsin)/MRT1 Neurotrypsin/Motopsin
RAC1 Ras-related C3 botulinum toxin substrate 1/p21-Rac1 p21-Rac1/TC25
RPL6 RPL6/TXREB1 60S ribosomal protein L6/TaxREB107
RPLP0 Ribosomal protein large P0 60S acidic ribosomal protein P0
SEMA3C Sema domain, immunoglobulin domain (Ig)/SemE Semaphorin-3C/Semaphorin E/Sema E
SF3B2 Splicing factor 3b, subunit 2, 145 kDa/Cus1 Splicing factor 3B subunit 2/SAP145
STRADA STE20-related kinase adaptor alpha/LYK5 /STRAD STRAD alpha
STRN4 Striatin, calmodulin-binding protein 4/ZIN Sriatin-4/Zinedin
TTC37 Tetratricopeptide repeat domain 37/KIAA0372 TPR repeat protein 37/Ski3/Thespin
YKT6 YKT6 v-SNARE homolog (S. cerevisiae)/“R-SNARE” Synaptobrevin homolog YKT6
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Table 4. Functions of predicted proteins encoded by differentially expressed genes.
Functions Genes Specific Functions for Proteins Encoded by Differentially Expressed Genes
Cell death and
cell survival
CALM2 Positive or negative regulator of apoptosis [1], regulator of autophagy [28]
CSDE1 Activates IRES-mediated translation of proapoptotic protein Apaf1 during apoptosis [29]
HSPA5
Activator of UPR-induced autophagy mediated by PERK/eIF2α/ATF4 pathway [30]
Inhibits p53-dependent apoptosis via PERK/eIF2 activation [31] and apoptosis via
PERK/eIF2/NF-κB [32]
Enhances apoptosis via PERK/eIF2/ATF4/CHOP pathway [32]
MAT2A Downregulated in renal cancer cells/tissues increasing a cell survival via HO-1 [33]
MORF4L1 Activator of tumour suppressor-mediated apoptosis
UP and nuclear ligand for proapoptotic
agent [34]
RAC1
Mediates cell survival via NF-κB when activated by SemaC342 and via PAKs25 and PI3K/Akt and
p38/MAPK pathways [35]
Promotes drug-induced apopotosis via JNK pathway [36]
RPLP0 Upregulated during drug-induced apoptosis [37]
SEMA3C Mediates cell survival by activating Rac1 and NF-κB [32]
YKT6 As a subunit of SNARE, mediates autophagy via comprising of phagophores [38]
Cell cycle
ARHGAP35 Positive regulator of cell cycle in lung carcinoma cells [39]
CALM2 Controls cell cycle progression [28]
CSDE1 Activates IRES-mediated translation of cell cycle regulator PITSLRE during mitosis [40]
MAT2A Inhibits the growth of liver cancer cells via SAMe [41]
MORF4L1 Activator of tumour suppressor-mediated cell cycle arrestUP accompanied with DNA repair [42]
RPL6 Inhibition of cell cycle via stabilization of p53 by suppressing MDM2 activity [43]
STRADA Mediates G1 cell cycle arrest via activating tumor suppressor LKB1 [44]
STRN4 Required for the completion of cytokinesis (abscission) while interacting with Mink1 [45]
YKT6 Over-expression alters cell cycle by increasing mitotic index, DNA synthesis and decreasing cellsize [46]
Cellular stress
CALM2 Regulates CaMKII, a significant mediator of ER stress induced apoptosis [28]
HSPA5
Sensor and inducer of ER stress [30,47] and overexpressed itself during ER stress [47]
Under ER stress, reduce translation and protein synthesis via PERK/eIF2 [5]
MORF4L1 Responses to DNA damage repairing DNA double strand breaks [48,49]
RAC1 Under cellular stress, mediates cell survival via PAKs [9], PI3K/Akt- and p38/MAPK-signaling [35]
RPL6 Under ribosomal stress, stabilize p53 by suppressing MDM2 activity [43]
RPLP0 Upregulated under cellular stress, e.g., ribosomal stress or drug-induced stress [12,50,51]
YKT6 Under ER stress, mediates apoptosis as a subunit of SNARE [52]
Cell shape,
motility and
polarity
ARHGAP35 Inhibits cell motility and migration via folic acid receptor/cSrc/p190RhoGAP pathway [53]
RAC1 Activator of cell motility via PAKs [54]
STRADA Regulation of cell polarity via activating LKB1 and via Rac1 and PAK1 [21]
Protein synthesis
ALKBH5 Involved in mRNA export and modifications [55]
CSDE1
RNA binding proteinUP and IRES transacting factor (ITAF) [56]
Under stress conditions, helps eIFs and other ITAFs to initiate alternative IRES-mediated protein
synthesis [56]
EIF3A Protein synthesis (translation)UP
HSPA5 Reduce translation and protein synthesis via PERK/eIF2 [32]
MORF4L1 Regulates chromatin remodeling during transcription via HAT and HDAC complexes [43]
RPL6 Ribosomal protein, protein synthesis (translation)UP
RPLP0 Ribosomal protein, protein synthesis (translation)UP
SF3B2 Splices mRNAUP
TTC37 As a subunit of SKI complex, mediates RNA surveillance with PAF complex [57] and assistsexosome in mRNA degradationUP
Ca2+-signaling
CALM2 Ca2+-binding protein, the major regulator of calcium-mediated signaling [28]
HSPA5 Ca2+-dependent chaperoneUP, involved in regulation of calcium leak during ER stress [47]
STRN4 Regulates Ca
2+-signaling via calmodulin [57], possibly a sensor responding to the concentration of
calcium [4]
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Table 4. Cont.
Functions Genes Specific Functions for Proteins Encoded by Differentially Expressed Genes
Enzymatic and
protein-protein
interactions
CALM2 Interacts calcium-dependently with hundreds of proteins [28], e.g., striatin family proteinsincluding zinedin [4,22]
EIF3A Subunit of eukaryotic initiation factor eIF3 with eIF3bUP
HSPA5 Binds and inactivate UPR-related signaling molecules PERK and ATF4 [30], interacts with p53 [23]
MAT2A Catalyzes the synthesis of biological methyl donor SAMeUP
MORF4L1 Subunit of transcription regulators HAT and HDAC complexes mediating chromatin [24]
RPL0 Ribosomal protein—A component of a ribosome large 60S subunitHGNC
RPLP0 Ribosomal protein—A component of a ribosome large 60S subunitHGNC
STRADA Subunit of LKB1-STRADα-MO25 and STRADα-PAK1 complexes [21]
STRN4 Regulatory subunit of PP2A in a STRIPAK complex [22], binds with several proteins includingMink1 [45] and calmodulin [4]
TTC37 Subunit of a SKI complex which assists exosome in a mRNA degradation
UP and associate with PAF
in transcription [57]
YKT6 Subunit of SNARE complexes which function in tranportationUP
HGNCHUGO Gene Nomenclature Committee and UPUniProt Database. Abbreviations: Akt = RAC-alpha
serine/threonine-protein kinase; Apaf1 = apoptotic protease activating factor 1; ATF4 = activating transcription
factor 4; CaMKII = Ca2+/calmodulin-dependent protein kinase; CHOP = C/EBP homology protein;
cSrc = Proto-oncogene tyrosine-protein kinase Src; eIF = eukaryotic initiation factor; ER = endoplasmic
reticulum; HAT = histone acetyltransferase; HDAC = histone deacetylase; HO-1 = heme oxygenase 1;
IRES = internal ribosomal entry site; ITAF = IRES transacting factor; JNK = c-Jun N-terminal kinase;
LKB1 = serine/threonine kinase 11; MAPK = mitogen-activated protein kinase; MDM2 = E3 ubiquitin-protein
ligase; Mink1 = misshapen-like kinase 1; MO25 = armadillo repeat scaffolding-like protein; NF-κB = nuclear
factor kappa B; PAF = RNA polymerase II associated factor; PAK = p21-activated kinase; PERK = pancreatic
eIF2-alpha kinase; PI3K = phosphoinotiside 3-kinase; PITSLRE = p34Cdc2 -related protein kinase;
PP2A = protein phosphatase 2A; SAMe = S-adenosyl-L-methionine; SKI = nuclear proto-oncoprotein;
SNARE = soluble N-ethylmaleimide-sensitive-factor attachment protein receptor; STRIPAK = striatin-interacting
phosphatase and kinase; UPR = unfolded protein response
At the time when these genes were detected, the cells contained both pro-apoptotic and
pro-survival signals and several proteins operating bifunctionally in cell survival and death either
activating or inhibiting, i.e., CALM2 (calmodulin) and RAC1 (Rac1/TC25). Interestingly, genes
related to ER stress (CALM2, HSPA5, YKT6), ribosomal stress (RPL6, RPLP0) and genomic stress
(MORF4L1) were over-expressed. Direct interactions with p53 were found for ER stress sensor HSPA5
(BiP, GRP78), which is suggested to inactivate p53 via binding [23] and for ribosomal protein RPL6,
which activates 53 via inhibiting Mdm2 [43]. STRADA and RAC1 modulate activations of p53 via
LKB1. STRADA mediates G1 cell cycle arrest [44] whereas RAC1 promotes cell survival via PAKs [54].
The major regulator of calcium-mediated signaling CALM2 (calmodulin) modulates cell survival and
death via different pathways, including JNK-pathway [28]. Under cellular stress, CSDE1 (UNR) helps
eIFs (e.g., eIF3) to initiate internal ribosomal entry site (IRES)-mediated translation and one of its
translational targets is a proapoptotic protein Apaf1 [29].
Interactions of seven identified genes with cellular stress, p53 and apoptotic cell death are
elucidated in Figure 5. Results showed the expression of several cellular stress-induced genes
responding to DNA damage (MORF4L1), ER stress (CALM2, HSPA5, YKT6) and ribosomal stress
(RPL6, RPLP0). Together with genes modulating cell survival (e.g., MAT2A, SEMA3C), cell cycle and
(e.g., ARHGAP35, STRADA, STRN4) and cell death (CSDE1, MORF4L1, RPLP0) these results suggest
the cellular stress, especially ER stress, response mediated by Ca2+ (CALM2, HSPA5, STRN4).
3. Discussion
Numerous plant phenolics have been discovered to cause p53 accumulation in cells and this effect
has been detected also in studies with flavonoid-rich plant extracts. Plant extracts are complicated
mixtures of numerous bioactive compounds, which makes their testing challenging. In the present
study, we have shown that the juniper extract can induce the p53 translocation from the cytosol into the
nucleus and this occurred before the DNA fragmentation and cell death in the human neuroblastoma
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SH-SY5Y cells. The cleavage of DNA molecule into smaller fragments was detected 24, 48 and 72 h after
the treatment while the most abundant accumulation and nuclear translocation of p53 occurred already
before the DNA damage after 24–48 h. The breakage of DNA is one of the final steps of apoptotic
cell death [26], and it is described as a hallmark of apoptosis [27]. Therefore, the p53-mediated DNA
fragmentation suggests that the juniper berry extract activated cell death was mediated by active
apoptotic mechanisms. Here, these changes were seen already at the early time point before a fully
activated cell death when no caspase activity was detected but p53 started to be activated.
The human neuroblastoma cells are shown to possess sensitivity on toxicity treatments [25] and
therefore chosen for testing of plant extracts in our studies [13]. The data concerning the role of
p53 in neuroblastoma is controversial but the SH-SY5Y cell line contains wild-type p53 capable to
transcription activity [58–60]. Mdm2 is the cytosolic main inactivator of p53 and the translocation
of p53 in nucleus requires a breakage of a Mdm2-p53 complex accompanied with acetylation and
phosphorylation [61]. Pro-apoptotic target genes of p53 include Pum, Noxa, Bax and Bid [62] but
the major transcription target is p21 which contribute cell cycle arrest in G1 and G2 phases [63].
Transcription-independent actions of p53 include the interactions of p53 with different proteins in
cytosol. For example p53 interacts with anti-apoptotic proteins Bcl-2 and Bcl-xL to enable pro-apoptotic
proteins Bax and Bid to translocate on mitochondrial outer membrane [64].
To understand the molecular mechanisms related to the observed cell death, differentially
expressed genes were identified and their functions analyzed. One aim of differential expression
analysis was to discover the specific genes involved in the cellular response for the juniper extract.
After treatment of neuroblastoma cells with 10 µg/mL of juniper berry extract, differentially expressed
genes were analyzed by cDNA RDA method. Gene expression was evaluated 12 h after treatment
with juniper berry extract, which reveals the upregulated genes before p53-mediated and DNA
fragmentation-related cell death occurred. We detected twenty-one genes upregulated in response
to the juniper extract (Table 2). The genes were classified to different functional groups (Table 4) to
alleviate their analysis. The functions of detected genes were involved in cell death and survival
(e.g., apoptosis and autophagy), cellular stress, cell cycle regulation, Ca2+-signaling, protein synthesis
and protein-protein interactions.
Endoplasmic reticulum (ER) stress is the cellular response to the toxic or harmful stimulus.
With this response the cells try to survive dangerous period and after removing the toxic stimulus,
the cells restore normal activity. However, when the stimulus is longer, the cells die via apoptosis.
Cells exploit ER stress caused by i.e., oxidative stress [65] to reduce misfolded and aggregated proteins,
which is reported to trigger cyclosporine A-induced autophagy and apoptosis in malignant glioma
cells with the inhibition mTOR/p70S6K1 pathway [66]. ER stress-induced glucose responsive protein
BiP/GRP78 (HSPA5) is a heat shock protein, which belongs to chaperones; proteins involved in folding
of macromolecules and expressed by ER stress [30]. BiP inhibits unfolded protein response (UPR)
pathway and mediates both prosurvival and proapoptotic effects, respectively. It binds overexpressed
wild-type p53 in nasopharyngeal carcinoma cells [23] and inhibits apoptosis via PERK/eIF2/NF-κB
pathway [32]. In addition, it activates caspase 12 [67] and PERK/eIF2/ATF4/CHOP-mediated
apoptosis [32].
Among other functions, ER is involved in Ca2+-homeostasis. Three overexpressed genes
(CALM2, HSPA5, STRN4) involved in Ca2+-signaling and homeostasis advocate the role of
calcium in stress response induced by the juniper berry extract. CALM2 (calmodulin) is a major
regulator of calcium-mediated signaling, including the regulation of CaMKII-mediated apoptosis via
JNK-pathway [28]. Interestingly, Rac1 has been found to promote JNK-mediated apoptosis as well [36]
and SEMA3C (Sema E) is one of its activators [68]. Another overexpressed gene STRN4 (zinedin)
regulates calmodulin-mediated signaling [57] and is claimed to act as a sensor for concentration
changes of Ca2+ [69]. Based on literature analysis and functional annotation of the list of genes,
the juniper extract induces ER stress accompanied with accumulation of p53 in neuroblastoma cells.
We also found that the apoptosis-related genes were activated by the juniper berry extract. Therefore,
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based on the gene expression profiling it is suggested that the treatment with 10 µg/mL of juniper
berry extract induces ER stress in the neuroblastoma cells.
Recent studies have revealed that some of the over-expressed proteins comprise specific cellular
stress, cell survival or death-mediating mechanisms beyond their well-known main functions (Table 4).
Ribosomal proteins encoded by RPLP0 and RPL6 are involved in protein translation but they also
possess extra-ribosomal functions. The upregulated RPL6 enhances cell growth and cell cycle
progression [70] and RPLP0 has been found to by up-regulated after induction with doxorubicin and
TRAIL [37]. The upregulated STRADA encodes STE20-related kinase adapter protein alpha (STRAD),
which activates the tumour suppressor LKB1—A kinase involved in cell polarity, energy metabolism
and cell growth [71]. LKB1 regulates cellular responses via different effectors and pathways including
AMP-activated protein kinase (AMPK) activation after metabolic stress [72] leading to activation
mTOR pathway and p53/p21-mediated cell cycle arrest and cell survival/apoptosis. Other tumour
suppressor function of LKB1 involves the inhibition of oncogenic protein Yap [73].
In order to understand the cell death-inducing actions of aqueous juniper berry extract, we
analyzed also its phenolic composition. To the best of our knowledge, this is the first report on the
phenolic composition of an aqueous juniper berry extract. Six flavones, five flavonols, one flavanol,
two phenolic acids and one biflavonoid were identified. We excluded the presence of volatile oil
components by gas chromatography-mass spectrometry (GC–MS) method, because among phenolics
volatile components of plants have shown to affect cellular mechanisms. Therefore, it is assumed
that the aqueous nonvolatile oil containing juniper extract would be safer due to its lower toxicity
in comparison with the volatile oil containing preparations. Otherwise, similar profiles of identified
compounds have been detected by Innocenti et al. [9] with ethanol extract and Miceli et al. [18] with
methanol extract. All of the identified compounds have been reported to possess different biological
activities. Therefore, it is likely that their effects might explain also our observations partly.
Since the effects of juniper berry extract shown in this study might be explained by the activities
of single phenolics, and the particular treatment concentrations were calculated for each phenolic
compound found in the composition analysis (Table 1). Phenolic concentrations of our extract varied
from 2.5 to 38.1 nM for single compounds. Literature search emphasized on neuroblastoma cells
showed that cell death, cell cycle, DNA fragmentation and p53-related activities were described for
identified compounds but usually at very high 100–1000-fold larger concentrations than in our study.
The present results indicate that there might be synergistic or combinatorial effects involved explaining
our results. e.g., 50 µM of apigenin decreased the SH-SY5Y cell viability after 24 h-treatment and
increased the amount of subG1 apoptotic SK-N-DZ cells, caspase 3, caspase 8 and the proapoptotic
ratio of Bax:Bcl-2 [74]. Apigenin concentration 1 µM decreased cell viability of SH-SY5Y cells 20%
after 24 h-treatment but the increase of the ratio Bax:Bcl-2 and caspases 3 and 9 were detected with
50 µM-treatment [75]. In addition, quercetin has shown to activate wild-type p53 by breaking the
Mdm2-p53 interaction [76].
There are only a few reports in literature to describe the biological effects of juniper berry
extract. Naturally occurring plant phenolics and extracts are known to possess both antioxidant
and pro-oxidant properties. The juniper berry extract used in this study has been evaluated for its
antioxidant and pro-oxidant activity in our own laboratory [14,15]. It was shown that the extract
possessed the pro-oxidant activity to stimulate protein degradation, and the antioxidant activity
to chelate iron and to scavenge hydroxyl radicals. These properties might be involved in the cell
death-inducing effects shown to plant phenolics. Tunón et al. [7] have tested traditional Swedish
medicinal plants for their anti-inflammatory properties based on the ethnopharmacological use of
plants. They showed that the extract from juniper berries possessed moderate inhibiting activity in
both prostaglandin and platelet activating factor (PAF)-induced exocytosis tests in vitro.
The present results suggest that the juniper extract activates ER stress pathway in the human
SH-SY5Y neuroblastoma cells accompanied with the increased amount and translocation of p53 from
the cytosol to the nucleus, the expression of specific cell cycle and cell survival regulating genes,
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the DNA fragmentation and the apoptotic cell death. This activation was seen already before the
caspase activity could be clearly detected. Therefore, it is concluded that the juniper berry extract is
able to reactivate the impaired p53 function and apoptosis typically found in the human neuroblastoma
cells. To the best of our knowledge, this is the first report of the phenolic composition of aqueous
juniper berry extract. When the traditional use of plant extracts—including juniper berries—is often
based on the aqueous extracts, these results improve the understanding of the possible mechanisms
behind the traditional use of them.
4. Materials and Methods
4.1. Plant Material, Solvents and Reference Substances
Ripe and dried berries of juniper (Juniperus communis L.) cultivated for spice were commercially
obtained from Paulig Ltd., Helsinki, Finland [77]. Details of origin or cultivation information are
not available for the test material. Acetonitrile and formic acid were of high performance liquid
chromatography (HPLC) or LC-MS grade. Flavonoids and phenolic acids such as amentoflavone,
apigenin-7-O-glucoside, hyperoside, kaempferol-3-O-glucoside, rutin, protocatechuic acid and
rosmarinic acid were purchased from Extrasynthese (Genay Cedex, France).
4.2. Aqueous Extraction of Juniper Berries
Ground juniper berries were extracted as described previously [15]. In brief, the extraction was
performed by boiling water during three-hour hydrodistillation, resulting in removal of volatile
oil. Hydrodistillation was performed using a Clevenger-type apparatus reported in European
Pharmacopoeia [78]. The aqueous extract was filtrated, freeze-dried and stored at 4 ˝C. The yield was
422 mg/g of ground berries [15].
4.3. Analysis of Volatile Oils by Gas Chromatography-Mass Spectrometry (GC–MS)
Volatile oils were removed from the extract during the extraction process by hydrodistillation.
The absence of volatile oil compounds was verified from hexane and ethyl acetate extracts of aqueous
juniper extract (50 mg/mL) by gas chromatography-mass spectrometry (GC–MS). Analyses were
carried out with GC–MS on a semipolar NB-54 column (HNU-Nordion Ltd., Helsinki, Finland).
Briefly, the column was combined to HP5890 GC coupled to an HP5970 quadrupole mass selective
detector, and helium was used as a carrier gas. Column temperature shifted during analyses from 50
to 250 ˝C at 10 ˝C/min.
4.4. Analysis of Phenolic Composition by High Performance Liquid Chromatography (HPLC)
The analyses were carried out using a Waters HPLC system (Waters Corp., Millford, MA, USA),
consisting of a Millenium chromatography manager, 717 autosampler, 2996 photodiode array (PDA)
detector, and 600 controller and a pump connected to an in-line degasser at room temperature.
Compounds of juniper berry extract were separated in Phenomenex Synergi Fusion-RP column,
150 mm ˆ 4.6 mm, 4 µm particles (Phenomenex, Torrance, CA, USA), using 0.1% formic acid (A)
and acetonitrile (B) as solvents. A gradient elution with a flow rate of 0.4 mL/min was 0–5 min,
5% B; 10 min, 90% A and 10% B; 15–18 min, 75% A and 25% B; 25–28 min, 65% A and 35% B; and
35–40 min, 100% B. The phenolic composition was determined by comparing the retention data and
absorption maxima of the UV spectra (200–500 nm) of reference compounds with the values of sample
components and earlier published data in literature.
4.5. LC-MS-UV Systems and Analyses
High performance liquid chromatography (HPLC) analyses were performed on Agilent 1100
HPLC system (Agilent Technologies, Santa Clara, CA, USA) fitted with the same column as in the
phenolic composition analysis, and by using corresponding mobile phases, gradient elution and
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flow-rate, with an injection volume of 40 µL at room temperature. The UV detection was made at 280
and 350 nm. An Agilent 6410 triple quadrupole MS with electrospray ion (ESI) source was used in
negative ion mode.
In the MS identification, full scan ESI-MS´ spectra were acquired at a mass range of m/z 100–800
and at fragmentor voltage of 135 V. Juniper extract components were identified by comparing HPLC
retention times, UV-vis spectra and MS fragmentation patterns with those of pure substances, and the
data published in the literature.
In multiple reaction monitoring (MRM) technique, the fragmentation energy for parentÑ product
ion (m/z) transitions were used at a range between 120 and 210 V for pure phenolic acids and flavonoids.
Quantitation of sample components was based on five-point calibration curves (r2 = 0.991–0.999)
prepared for reference substances. Other phenolics, not available as pure compounds, were quantified
by using rutin as a standard.
Separation in ultra-performance liquid chromatography (UPLC) analyses was tested under
different conditions regarding column, solvent A, gradient elution and flow rate. The analyses
were performed on Waters Acquity UPLC™ combined with Waters QTOF Premier MS by using
an Acquity™ BEH C18 column (100 mm ˆ 2.1 mm, 1.7 µm). Gradient solvent system consisted of
water/acetonitrile/formic acid (95:5:0.1, solvent A) and acetonitrile (solvent B). The proportion of B
increased from 15% to 50% in 17.5 min and to 100% in 2.5 min. The flow rate was 0.3 mL/min and
injection volume 5 µL. MS data were collected in ESI´ mode at a mass range of m/z 100–1000, and
leucine enkephaline was used as the lock spray reagent.
4.6. Cell Culture and Treatments
Human SH-SY5Y neuroblastoma cells were cultured in Dulbeccos’s modified eagle medium:
nutrient mixture F-12 (1:1) containing 15 mM HEPES buffer and L-glutamine and supplemented with
15% heat-inactivated foetal bovine serum, antibiotic mixture of penicillin (170 U/mL) and streptomycin
(170 µg/mL) and 1% non-essential amino acids. Continuous culturing of cells was performed at 37 ˝C
in a humidified atmosphere containing 5% CO2 in air. Cells were treated on 6 cm plates for DNA
fragmentation assay and Western blot analysis, and on 10 cm plates for cDNA-RDA assay. For cell
experiments, the juniper berry extract was dissolved in mQ-H2O at the concentration of 50 mg/mL.
4.7. Preparation of Protein Samples for Western Blot Analysis
The SH-SY5Y cells were collected using a cell scraper at different time points after treatment with
10 µg/mL of juniper berry extract, and spun down by centrifugation at 5000ˆ g for 5 min. Cell pellets
were stored at ´80 ˝C until nuclear and cytoplasmic proteins were extracted by using a commercial kit
(ProteoJET Cytoplasmic and Nuclear Protein Extraction Kit, Fermentas, Espoo, Finland) according to
manufacturer’s instructions. Briefly, cell lysis and cytoplasmic protein extraction were performed by
incubating cells with a cell lysis buffer supplemented with protease inhibitor. Cytoplasmic proteins
were separated from nuclei by centrifugation at 1000ˆ g for 10 min. Nuclear proteins were extracted
from washed nuclei with nuclei lysis reagent by shaking samples at 1200 rpm for 15 min and separating
proteins by centrifugation at 16,000ˆ g for 15 min. All collection and extraction steps were performed
on ice or at 4 ˝C. Protein samples were stored at ´80 ˝C until protein amounts were determined by
a colorimetric bicinchoninic acid (BCA) assay (Thermo Scientific, Waltham, MA, USA).
4.8. Western Blot Analysis of Cytoplasmic and Nuclear p53
Western blot analysis was performed as previously described by Lantto et al. [13].
Cytoplasmic proteins (15 µg) and nuclear proteins (30 µg) were first separated in 12% SDS-PAGE
gel and transferred onto nitrocellulose membrane. Nonspecific binding of antibodies was blocked by
5% non-fat milk powder before exposing the membrane with a monoclonal p53 and β-actin primary
antibodies (DO-7, Novocastra, Hämeenlinna, Finland; A1973, Sigma, Helsinki, Finland). To enable the
visualization of proteins, the membranes were exposed to a horseradish peroxidase (HRP)-conjugated
Int. J. Mol. Sci. 2016, 17, 1113 15 of 20
secondary antibody (HAF007, R&D Systems, Abingdon, UK) and a chemiluminescence reaction was
induced by HRP-substrate (SuperSignal West Pico, Thermo Scientific, IL, USA). Proteins were detected
and analyzed with GeneGnome system and GeneTools programme (Syngene, Frederick, MD, USA).
4.9. DNA Fragmentation
DNA fragmentation was determined by agarose gel electrophoresis as previously described [24,79],
with minor modifications. In brief, SH-SY5Y cells were treated with 10 µg/mL of juniper berry extract.
Both floating and attached cells were collected at different time points and centrifuged for 5 min at
5000ˆ g at 37 ˝C. The pellets were resuspended in lysis buffer (0.2% Triton X-100; 10 mM Tris-HCl,
pH 7.5, and 10 mM EDTA in water) for 20 min on ice. After a centrifugation of 20 min at 16,000ˆ g
at 4 ˝C, the supernatants were collected and incubated with RNAse enzyme (final concentration
of 100 µg/mL) for 1 h at 37 ˝C. DNA was purified with phenol/chloroform and precipitated with
100% ethanol overnight at ´20 ˝C. Precipitated DNA was collected by centrifugation for 30 min at
12,000ˆ g at room temperature (RT) and washed with 70% ethanol. The pellets were dissolved in TE
buffer (10 mM Tris-HCl, pH 8.0, and 10 mM EDTA in water) and mixed with DNA loading dye for
electrophoresis. DNA fragments were separated in 2% agarose gel in TAE buffer (40 mM Tris acetate,
2 mM EDTA, pH 8,5) for 2 h 40 min using a voltage of 100 V. The image was photographed with
a charge coupled device (CCD) camera (UltraLum, Claremont, CA, USA) under UV light.
4.10. cDNA Representational Difference Analysis (RDA)
Total RNA was isolated from juniper berry extract-treated and untreated cell samples by
TRIzol-method (Gibco BRL, Gaithersburg, MD, USA). The total RNA samples were stored at
´80 ˝C until the concentration, purity and integrity of total RNA were determined by 1.5%
agarose gel and spectrophotometry. Double-stranded cDNA was synthesised from the total
RNA by SuperScript™ Double-Stranded cDNA Synthesis kit (Invitrogen, Gaithersburg, MD, USA)
according to manufacturer’s instructions. Representational difference analysis was performed
as previously described by Hubank et al. [80] with some modifications. The ds-cDNA was
digested with DpnII-enzyme (R0543S, BioLabs, Ipswich, MA, USA) and desalted R-Bgl-12/24 linkers
(TAG Copenhagen, Frederiksberg, Denmark) were ligated to enable the PCR amplification with
R-Bgl-24 primer. PCR products were cut by DpnII-enzyme to remove R-linkers and to produce driver
sample which represents gene expression of untreated control cells. Tester sample representing gene
expression of juniper berry extract-treated cells was prepared from cut PCR products by purifying
R-linkers from the samples and ligating J-Bgl-12/24 linkers (TAG Copenhagen). The first difference
products (DP1) were generated by hybridizing a mixture of tester and driver in a ratio of 1:100
followed by an exponential PCR amplification of tester:tester hybrids. Driver:tester and driver:driver
hybrids were eliminated. To remove false annealing products, the second difference products
(DP2) were produced. The DP1 were cut, ligated to N-Bgl-12/24 linkers (TAG Copenhagen) and
hybridized with the driver at the ratio of 1:2000. After amplification by PCR the DP2 were cut
with DpnII-enzyme, separated and purified by gel electrophoresis and ligated with BamHI-digested
pGEM vector (Fermentas). The DP2 were cloned by transferring vectors into E. coli DH10B (TOP10)
(Invitrogen) by electroporation. Plasmids were purified and the plasmid DNA analyzed by cycle
sequencing (PE Applied Biosystems, 3730 DNA Analyzer, Tartu, Estonia) using M13 forward primers
(BigDye, Applied Biosystems, Carlsbad, CA, USA).
4.11. Statistical Analysis
The western blot results are shown as arithmetic means ˘ SEM from three independent
experiments. Comparisons between untreated control cells and treated cells were evaluated using
a one-tailed Student’s t-test, p < 0.05 was defined as significant. Morphological changes of cells are
shown as an arithmetic mean˘ SD complemented with a median from three independent experiments.
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